Delivery Order SPE2DB24D9223-SPE2DB25FKELJ
- Not listed
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on July 21, 2025, carries a ceiling value of $12,782.32 and is scheduled for ultimate completion by August 11, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a $12.78K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240 count). The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. for the supply of Alecensa 150 mg capsules (240-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of September 10, 2025. This award carries no set-aside designation, allowing the vendor to compete on...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. for the supply of Alecensa 150 mg capsules (240 count units). The contract was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, and carries a firm fixed-price structure with no set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters operations. DMS Pharmaceutical Group Inc., a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,897.20 contract is for the delivery of Alecensa 150 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency for 240 units of Alecensa 150 mg capsules, valued at $21,731.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. The award represents one of numerous delivery orders issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $24,948.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Alecensa 150 mg capsules and has a completion date of November 14, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications,...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $24,948.60 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 240 capsules of the drug Alecensa (150 mg) with a completion date of March 14, 2024. This contract award is associated with a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, which has a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $12,782.32 for 240 tablets of Alecensa 150mg. The award, issued on August 28, 2025, with an ultimate completion date of September 18, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $24,948.60 and a period of performance through June 5, 2024. Under this contract, DMS Pharmaceutical Group will provide a branded pharmaceutical product, Alecensa 150 mg capsules, to support the recurring medical supply needs of military health...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKELJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-unit quantity). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a $499,999,999 blanket purchasing agreement valid through November 2026 that authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards encompassing branded and generic prescription drugs, biologics, and specialized medical consumables. The company's experience delivering oncology treatments, vaccines, and other pharmaceutical products to military health facilities positions it to efficiently fulfill this Alecensa order, an oral medication used in cancer treatment. This delivery order exemplifies the DLA's operational model of leveraging existing indefinite delivery contracts to procure specific pharmaceutical items on an as-needed basis, enabling rapid response to federal healthcare supply requirements while maintaining cost efficiency through established pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/3/25 |